| Acute Ischemic Stroke Management | Lifetime | 185 | JP 2 | 99.39 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 238 | JP 2 | 99.26 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 77 | JP 3 | 99.14 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 403 | JP 4 | 98.85 |
| Stroke Rehabilitation and Recovery | Lifetime | 283 | JP 2 | 98.79 |
| Neurosurgical Procedures and Complications | Lifetime | 139 | JP 3 | 98.52 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 509 | JP 14 | 98.75 |
| Neurological and metabolic disorders | Lifetime | 100 | JP 3 | 97.55 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 766 | JP 18 | 97.98 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 445 | JP 8 | 97.99 |
| Intracranial Aneurysms: Treatment and Complications | Lifetime | 735 | JP 92 | 97.02 |
| Neurological Complications and Syndromes | Lifetime | 232 | JP 18 | 95.95 |
| Aortic Thrombus and Embolism | Lifetime | 62 | JP 4 | 93.97 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 600 | JP 45 | 94.60 |
| Cerebral Venous Sinus Thrombosis | Lifetime | 595 | JP 20 | 94.29 |
| Cardiac tumors and thrombi | Lifetime | 809 | JP 43 | 93.72 |
| Cerebrovascular and genetic disorders | Lifetime | 286 | JP 27 | 89.83 |
| Moyamoya disease diagnosis and treatment | Lifetime | 601 | JP 139 | 90.48 |
| Spinal Hematomas and Complications | Lifetime | 983 | JP 163 | 79.73 |
| Oropharyngeal Anatomy and Pathologies | Lifetime | 805 | JP 78 | 70.87 |
| Acute Ischemic Stroke Management | 2021-2025 | 58 | JP 2 | 99.41 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 18 | JP 1 | 98.87 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 124 | JP 3 | 98.29 |
| Stroke Rehabilitation and Recovery | 2021-2025 | 145 | JP 2 | 97.41 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 228 | JP 5 | 98.26 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 198 | JP 4 | 97.67 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 137 | JP 7 | 96.76 |
| Cardiac Arrhythmias and Treatments | 2021-2025 | 823 | JP 53 | 93.92 |
| Peripheral Artery Disease Management | 2021-2025 | 361 | JP 30 | 91.48 |
| Neurosurgical Procedures and Complications | 2021-2025 | 258 | JP 3 | 89.28 |
| Traumatic Brain Injury and Neurovascular Disturbances | 2021-2025 | 909 | JP 14 | 89.95 |
| Neurological and metabolic disorders | 2021-2025 | 100 | JP 12 | 79.96 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 280 | JP 6 | 77.97 |
| S100 Proteins and Annexins | 2021-2025 | 648 | JP 8 | 66.70 |
| Neurological Complications and Syndromes | 2021-2025 | 809 | JP 73 | 52.08 |
| Cerebrovascular and genetic disorders | 2021-2025 | 572 | JP 40 | 44.05 |
